E-Selectin as a Marker of Endothelial Dysfunction in Patients with Coronary Artery Disease Including Those with Type 2 Diabetes Mellitus

Aim To determine concentration of the endothelial dysfunction (ED) marker, serum E-selectine, in patients with ischemic heart disease (IHD) in combination with type 2 diabetes mellitus (DM) and without DM.
Material and methods The study included 60 IHD patients; 31 of them also had type 2 DM. E-selectin was measured in blood of all patients. In addition, a comprehensive evaluation of the morpho-functional condition of large blood vessels and microvasculature (MV) was performed by laser finger plethysmography (LFP) and nailfold computed videocapillaroscopy (CVC).
Results Concentration of E-selectin was increased in IHD patients with type 2 DM (35.2 [29.0; 47.35] ng / ml vs. 31.7 [20.85; 36.68] ng / ml for IHD patients; p=0.028). A significant (p=0.018 and 0.016, respectively) decrease in the phase shift was observed in IHD patients with type 2 DM ( – 4.4 [ – 8.7; – 2.45] ms) compared to IHD patients ( – 1.9 [ – 3.95; – 0.38] ms). The capillary density evaluated in the venous occlusion test was reduced in IHD patients with type 2 DM (67.70 [57.83; 80.69]) compared to IHD patients (80.80 [69.05; 99.08]).
Conclusion The signs of ED observed in patients of both groups were more pronounced in IHD patients with type 2 DM.

1. World Health Organization. World Heart Day. Scale up prevention of heart attack and stroke. 2019. [Library Catalog: www.who.int] [Internet] 2019. Available at: http://www.who.int/cardiovascular_diseases/world-heart-day/en/

2. World Health Organization. WHO: Global report on diabetes. 2016. [Internet] 2016. Available at: http://www.who.int/diabetes/global-report/en/

3. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice. 2019;157:107843. DOI: 10.1016/j.diabres.2019.107843

4. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States. Atlanta, GA: U.S. Department of Health and Human Services. 2011. [Av. at: http://www.diabetesincontrol.com/wp-content/uploads/PDF/ndep_diabetes_facts_2011.pdf]

5. Hammoud T, Tanguay J-F, Bourassa MG. Management of coronary artery disease: therapeutic options in patients with diabetes. Journal of the American College of Cardiology. 2000;36(2):355–65. DOI: 10.1016/S0735-1097(00)00732-4

6. Norhammar A, Malmberg K, Diderholm E, Lagerqvist B, Lindahl B, Rydén L et al. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. Journal of the American College of Cardiology. 2004;43(4):585–91. DOI: 10.1016/j.jacc.2003.08.050

7. Creager MA, Lüscher TF, prepared with the assistance of, Cosentino F, Beckman JA. Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I. Circulation. 2003;108(12):1527–32. DOI: 10.1161/01.CIR.0000091257.27563.32

8. Federal State Statistics Service. Death statistics according to Rosstat. Av. at: https://rosinfostat.ru/smertnost/. 2018. [Russian: Федеральная служба государственной статистики. Статистика смертности по данным Росстат. 2018. Доступно на: https://rosinfostat.ru/smertnost/] [Internet] 2018.

9. Dhananjayan R, Koundinya KSS, Malati T, Kutala VK. Endothelial Dysfunction in Type 2 Diabetes Mellitus. Indian Journal of Clinical Biochemistry. 2016;31(4):372–9. DOI: 10.1007/s12291-015-0516-y

10. Grant PJ. Diabetes mellitus as a prothrombotic condition. Journal of Internal Medicine. 2007;262(2):157–72. DOI: 10.1111/j.1365-2796.2007.01824.x

11. Gaiz A, Mosawy S, Colson N, Singh I. Thrombotic and cardiovascular risks in type two diabetes; Role of platelet hyperactivity. Biomedicine & Pharmacotherapy. 2017;94:679–86. DOI: 10.1016/j.biopha.2017.07.121

12. Ferroni P, Basili S, Falco A, Davi G. Platelet activation in type 2 diabetes mellitus. Journal of Thrombosis and Haemostasis. 2004;2(8):1282–91. DOI: 10.1111/j.1538-7836.2004.00836.x

13. Ferreiro JL, Gómez-Hospital JA, Angiolillo DJ. Review article: Platelet abnormalities in diabetes mellitus. Diabetes and Vascular Disease Research. 2010;7(4):251–9. DOI: 10.1177/1479164110383994

14. Kakouros N, Rade JJ, Kourliouros A, Resar JR. Platelet Function in Patients with Diabetes Mellitus: From a Theoretical to a Practical Perspective. International Journal of Endocrinology. 2011;2011:1–14. DOI: 10.1155/2011/742719

15. Münzel T, Sinning C, Post F, Warnholtz A, Schulz E. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Annals of Medicine. 2008;40(3):180–96. DOI: 10.1080/07853890701854702

16. Murohara T, Buerke M, Lefer AM. Polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction. Role of selectins. Arteriosclerosis and Thrombosis: A Journal of Vascular Biology. 1994;14(9):1509–19. DOI: 10.1161/01.ATV.14.9.1509

17. Demeyer G, Herman A. Vascular endothelial dysfunction. Progress in Cardiovascular Diseases. 1997;39(4):325–42. DOI: 10.1016/S0033-0620(97)80031-X

18. Calder PC, Ahluwalia N, Albers R, Bosco N, Bourdet-Sicard R, Haller D et al. A Consideration of Biomarkers to be Used for Evaluation of Inflammation in Human Nutritional Studies. British Journal of Nutrition. 2013;109(S1):S1–34. DOI: 10.1017/S0007114512005119

19. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis. 2003;170(2):191–203. DOI: 10.1016/S0021-9150(03)00097-2

20. Tretjakovs P, Jurka A, Bormane I, Mikelsone I, Elksne K, Krievina G et al. Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina. Clinica Chimica Acta. 2012;413(1–2):25–9. DOI: 10.1016/j.cca.2011.10.009

21. Senen K, Ileri M, Alper A, Yetkin F, Atak R, Hisar I et al. Increased Levels of Soluble Adhesion Molecules E-Selectin and P-Selectin in Patients with Cardiac Syndrome X. Angiology. 2005;56(3):273–7. DOI: 10.1177/000331970505600306

22. Semaan HB, Gurbel PA, Anderson JL, Muhlestein JB, Carlquist JF, Horne BD et al. Soluble VCAM-1 and E-Selectin, but Not ICAM-1 Discriminate Endothelial Injury in Patients with Documented Coronary Artery Disease. Cardiology. 2000;93(1–2):7–10. DOI: 10.1159/000006995

23. Stanojevic NB, Ivanovic ZJ, Djurovic S, Kalimanovska VS, Spasic S, Ostric DK et al. Lack of Association Between Low HDL-cholesterol and Elevated Circulating Cellular Adhesion Molecules in Normolipidemic CAD Patients and Healthy Subjects. International Heart Journal. 2005;46(4):593–600. DOI: 10.1536/ihj.46.593

24. Hajilooi M, Sanati A, Ahmadieh A, Ghofraniha A, Massoud A. Circulating ICAM‐1, VCAM‐1, E‐Selectin, P‐Selectin, and TNFRII in Patients with Coronary Artery Disease. Immunological Investigations. 2004;33(3):263–75. DOI: 10.1081/IMM-120037275

25. Belenkov Yu.N., Shchendrygina A.A., Privalova E.V., Kuznetsov A.P., Kuznetsov M.I. Method for assessing the state of the vascular bed in healthy individuals with cardiovascular risk factors and in cardiovascular patients. RU 2508900 C1. Zayavka 2012156011/14 from 24.12.2012. 2012. [Russian: Беленков Ю.Н., Щендрыгина А.А., Привалова Е.В., Кузнецов А.П., Кузнецов М.И. Способ оценки состояния сосудистого русла у здоровых лиц с факторами риска развития сердечно-сосудистых заболеваний и больных сердечно-сосудистыми заболеваниями. Патент RU 2508900 C1. Заявка 2012156011/14 от 24.12.2012. Доступно на: https://yandex.ru/patents/doc/RU2508900C1_20140310]

26. Belenkov Yu.N., Privalova E.V., Danilogorskaya Yu.A., Shchendrygina A.A. Structural and functional changes in capillary microcirculation in patients with cardiovascular diseases (arterial hypertension, coronary heart disease, chronic heart failure) observed during computer videocapillaroscopy. Cardiology and cardiovascular surgery. 2012;5(2):49–56. [Russian: Беленков Ю.Н., Привалова Е.В., Данилогорская Ю.А., Щендрыгина А.А. Структурные и функциональные изменения микроциркуляторного русла на уровне капилляров, у больных сердечно-сосудистыми заболеваниями (артериальная гипертония, ишемическая болезнь сердца, хроническая сердечная недостаточность), которые можно наблюдать в ходе компьютерной видеокапилляроскопии. Кардиология и сердечно-сосудистая хирургия. 2012;5(2):49-56.]